United Therapeutics (UTHR) Tops Q3 EPS by 120c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $563.70 +3.01%
EPS Growth %: +11.9%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +11.9%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.55, $1.20 better than the analyst estimate of $2.35. Revenue for the quarter came in at $386.2 million versus the consensus estimate of $363.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Goldman Sachs Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Sell
- Goldman Sachs Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
